Recently renamed the Proteomics Shared Resource, this facility, established in 1988, provides protein analysis using a combination of technologies: mass mapping and identification of unknown proteins from databases after solution or in-gel digests, sequencing by Edman degradation or by tandem mass spectrometry; 2D gels; MALDI-TOF or electrospray ionization mass spectrometry of natural and recombinant proteins and candidate drugs, HPLC-MS identification of components of macromolecular complexes, and identification of sites of posttranslational modifications. The JASCO J-720 circular dichroism spectropolarimeter is used for studies of solution conformation, and following reactions of enzymes specific for chiral substrates. The facility carries out routine and specialized peptide synthesis. The latter includes, beyond synthesis of peptide antigens and substrates, structural quality peptides (both natural and 15N labeled) for NMR analysis, peptides with modified groups, peptide baits for affinity capture of macromolecular complexes, and peptide scans of virus polypeptides for immune response assays. Since 1996, the Facility has added 2D gel capabilities, mass mapping coupled to database searches for protein identification, hydrogen deuterium exchange coupled to mass spectrometry for probing protein dynamics, synthesis of long peptides suitable for structural analysis, and high sensitivity separations. Four mass spectrometers of higher resolution and sensitivity have been acquired within the last two years: a PE-Biosystems DE STR mass spectrometer with delayed extraction, reflectron, high voltage detector and collision cell; a Finnigan LCQ ion trap mass spectrometer with a nanospray source; a Sciex API-365 electrospray ionization, triple quadrupole mass spectrometer with microionspray source; and a PE-Biosystems Mariner ESI TOF mass spectrometer with microionspray source. High sensitivity HPLCs for both off-line and on-line (linked to mass spectrometry) work have also helped the step-up to subpicomole detection sensitivity of proteins and peptides. The IPGphor high voltage system and the two Multiphor II flatbed units have added the capability for two-dimensional (2D) gel electrophoresis using immobilized ampholines for the isoelectric focusing dimension. New image and data handling software for 2D gels is being added. An Affinity Sensors surface plasmon resonance unit and Beckman XL-A analytical ultracentrifuge have added new experimental approaches for understanding biomolecular interactions in protein assembly. As scientific staff has turned over, new scientists at higher levels of experience have been added to the Proteomics Facility, building on the core of senior staff.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-31
Application #
6615181
Study Section
Project Start
2002-07-29
Project End
2003-06-30
Budget Start
Budget End
Support Year
31
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Ruiz, Penelope D; Gamble, Matthew J (2018) MacroH2A1 chromatin specification requires its docking domain and acetylation of H2B lysine 20. Nat Commun 9:5143
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Rohan, Thomas; Ye, Kenny; Wang, Yihong et al. (2018) MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One 13:e0191814
Frimer, Marina; Miller, Eirwen M; Shankar, Viswanathan et al. (2018) Adjuvant Pelvic Radiation ""Sandwiched"" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. Int J Gynecol Cancer 28:1781-1788
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Lee, Chang-Hyun; Kiparaki, Marianthi; Blanco, Jorge et al. (2018) A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell 46:456-469.e4
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131

Showing the most recent 10 out of 1508 publications